One-year Clinical Prediction in Chinese Ischemic Stroke Patients Using the CHADS2 and CHA2DS2-VASc Scores: The China National Stroke Registry

CNS Neuroscience and Therapeutics

Volumn 18, Issue 12, 2012, Pages 988-993

  Li, Shu Ya ^a   Zhao, Xing Quan ^a   Wang, Chun Xue ^a   Liu, Li Ping ^a   Liu, Gai Fen ^a   Wang, Yi long ^a   Wang, Yong Jun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Clinical prediction; Risk stratification; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CHINA; CHINESE; COHORT ANALYSIS; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PREDICTION; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK FACTOR; SCORING SYSTEM; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; ATRIAL FIBRILLATION; CHINA; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LOGISTIC MODELS; MALE; PREDICTIVE VALUE OF TESTS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SELF REPORT; SEVERITY OF ILLNESS INDEX; STROKE; SURVIVAL RATE; VITAMIN K;

EID: 84870434028     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12021     Document Type: Article

References (36)

1. Ihle-Hansen H, Thommessen B, Wyller TB, Engedal K, Fure B. Risk factors for and incidence of subtypes of ischemic stroke. Funct Neurol 2012;27:35-40.
2. Lin S, Wu B, Hao ZL, et al. Characteristics, treatment and outcome of ischemic stroke with atrial fibrillation in a chinese hospital-based stroke study. Cerebrovasc Dis 2011;31:419-426.
3. Wen-Hang QI. Retrospective investigation of hospitalised patients with atrial fibrillation in mainland china. Int J Cardiol 2005;105:283-287.
4. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the national registry of atrial fibrillation. JAMA 2001;285:2864-2870.
5. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. Chest 2010;137:263-272.
6. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the european society of cardiology (esc). Eur Heart J 2010;31:2369-2429.
7. Lip GY, Halperin JL. Improving stroke risk stratification in atrial fibrillation. Am J Med 2010;123:484-488.
8. Keogh C, Wallace E, Dillon C, Dimitrov BD, Fahey T. Validation of the chads2 clinical prediction rule to predict ischaemic stroke. A systematic review and meta-analysis. Thromb Haemost 2011;106:528-538.
9. Olesen JB, Lip GY, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: Nationwide cohort study. BMJ 2011;342:d124.
10. Lip GY, Frison L, Halperin JL, Lane DA. Identifying patients at high risk for stroke despite anticoagulation: A comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort. Stroke 2010;41:2731-2738.
11. Hong HJ, Kim YD, Cha MJ, et al. Early neurological outcomes according to CHADS(2) score in stroke patients with non-valvular atrial fibrillation. Eur J Neurol 2012;19:284-290.
12. Sato S, Yazawa Y, Itabashi R, Tsukita K, Fujiwara S, Furui E. Pre-admission CHADS2 score is related to severity and outcome of stroke. J Neurol Sci 2011;307:149-152.
13. Giralt-Steinhauer E, Cuadrado-Godia E, Ois A, et al. CHA(2)DS (2)-VASc score and prognosis in ischemic strokes with atrial fibrillation. J Neurol 2012;259:745-751.
14. Wang YJ, Zhang SM, Zhang L, et al. Chinese guidelines for the secondary prevention of ischemic stroke and transient ischemic attack 2010. CNS Neurosci Ther 2012;18:93-101.
15. Wang Y, Cui L, Ji X, et al. The china national stroke registry for patients with acute cerebrovascular events: Design, rationale, and baseline patient characteristics. Int J Stroke 2011;6:355-361.
16. WHO Task Force on stroke and other cerebrovascular disorders. Stroke-1989: Recommendations on stroke prevention, diagnosis and therapy. Stroke 1989;20:1407-1421.
17. Guo Y, Wu Q, Zhang L, et al. Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk? Clin Interv Aging 2010;5:157-162.
18. Ho LY, Siu CW, Yue WS, Lau CP, Lip GY, Tse HF. Safety and efficacy of oral anticoagulation therapy in chinese patients with concomitant atrial fibrillation and hypertension. J Hum Hypertens 2011;25:304-310.
19. Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY. The value of the cha2ds2-vasc score for refining stroke risk stratification in patients with atrial fibrillation with a chads2 score 0-1: A nationwide cohort study. Thromb Haemost 2012;107:1172-1179.
20. Pieri A, Lopes TO, Gabbai AA. Stratification with cha2ds2-vasc score is better than chads2 score in reducing ischemic stroke risk in patients with atrial fibrillation. Int J Stroke 2011;6:466.
21. Kim YD, Cha MJ, Kim J, et al. Increases in Cerebral Atherosclerosis According to CHADS2 Scores in Patients With Stroke With Nonvalvular Atrial Fibrillation. Stroke 2011;42:930-934.
22. Hart RG, Pearce LA. Current status of stroke risk stratification in patients with atrial fibrillation. Stroke 2009;40:2607-2610.
23. Independent predictors of stroke in patients with atrial fibrillation. A systematic review. Neurology 2007;69:546-554.
24. Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: The rotterdam study. Eur Heart J 2006;27:949-953.
25. Deng YX, Wang YL, Gao BQ, et al. Age Differences in Clinical Characteristics, Health care, and Outcomes after Ischemic Stroke in China. CNS Neurosci Ther 2012;18:819-826.
26. Olesen JB, Fauchier L, Lane DA, Taillandier S, Lip GY. Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: The loire valley atrial fibrillation project. Chest 2012;141:147-153.
27. Mant J, Hobbs FD, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the birmingham atrial fibrillation treatment of the aged study, bafta): A randomised controlled trial. Lancet 2007;370:493-503.
28. Muir KW, Weir CJ, Murray GD, Povey C, Lees KR. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke 1996;27:1817-1820.
29. Goldstein LB, Samsa GP. Reliability of the national institutes of health stroke scale. Extension to non-neurologists in the context of a clinical trial. Stroke 1997;28:307-310.
30. Smith EE, Shobha N, Dai D, et al. Risk score for in-hospital ischemic stroke mortality derived and validated within the get with the guidelines-stroke program. Circulation 2010;122:1496-1504.
31. Lamassa M, Di Carlo A, Pracucci G, et al. Characteristics, outcome, and care of stroke associated with atrial fibrillation in europe: Data from a multicenter multinational hospital-based registry (the european community stroke project). Stroke 2001;32:392-398.
32. Hannon N, Sheehan O, Kelly L, et al. Stroke associated with atrial fibrillation-incidence and early outcomes in the north dublin population stroke study. Cerebrovasc Dis 2010;29:43-49.
33. Johnston KC, Wagner DP, Wang XQ, et al. Validation of an acute ischemic stroke model: Does diffusion-weighted imaging lesion volume offer a clinically significant improvement in prediction of outcome? Stroke 2007;38:1820-1825.
34. Weimar C, Konig IR, Kraywinkel K, Ziegler A, Diener HC. Age and national institutes of health stroke scale score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: Development and external validation of prognostic models. Stroke 2004;35:158-162.
35. Hohnloser SH, Pajitnev D, Pogue J, et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: An ACTIVE W substudy. J Am Coll Cardiol 2007;50:2156-2161.
36. Rizos T, Wagner A, Jenetzky E, et al. Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients. Cerebrovasc Dis 2011;32:276-282.